Sign in / Join Now
ETFs & Funds
say they have funding until 2017 so why do they keep diluting their shares? Especially since they just did a reverse split.
I don't find that shareholder friendly.
I found that $
are just rubbish, it's even more apparent when market is going through tough time!
so they can fund p3 3100 solo
They said incremental pricing to fund p3 unless a partner comes along. Either way it's still a ways off, they won't do it at this price
Add a reply...
Latest StockTalks »
people get INO breaking news and analysis by email alert.
Get email alerts on INO »
Inovio Pharmaceuticals, Inc.
Get latest price
From other sites
Inovio Pharmaceuticals Awarded $6.1 Million Sub-grant Through Wistar Institute To Develop DNA-based Monoclonal Antibodies Against Zika Virus
at TheStreet (Thu, 9:00AM)
Inovio's Co-Founder And Chair Of Its Scientific Advisory Board Selected As A Top 20 Translational Researcher
at TheStreet (Nov 21, 2016)
Inovio's Cancer Immunotherapy (INO-3112) Generates T Cell Immune Responses In Tumor Tissue And Peripheral Blood In Patients With HPV-Associated Head And Neck Cancer
at TheStreet (Nov 14, 2016)
Inovio Pharmaceuticals Zika Vaccine Protects Animals from Infection, Brain Damage And Death
at TheStreet (Nov 10, 2016)
Inovio (INO) Reports Wider Loss in Q3, Revenues Beat
at Zacks.com (Nov 9, 2016)